LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.33 | 17.25 | 4420 | 4651 | 0.9503 | 0.9874 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.33 | 17.25 | 126 | 4651 | 0.0271 | 0.2792 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 50.33 | 17.25 | 4648 | 4651 | 0.9993 | 0.9998 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.30 | 17.25 | 808 | 4798 | 0.1684 | 0.6060 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.30 | 17.25 | 4795 | 4798 | 0.9993 | 0.9998 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.30 | 17.25 | 81 | 4798 | 0.0169 | 0.2098 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 52.30 | 17.25 | 5035 | 4798 | 1.0493 | 1.0119 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.27 | 17.25 | 1026 | 4884 | 0.2101 | 0.6513 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.27 | 17.25 | 5132 | 4884 | 1.0508 | 1.0122 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.27 | 17.25 | 95 | 4884 | 0.0195 | 0.2330 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 54.27 | 17.25 | 5366 | 4884 | 1.0987 | 1.0232 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.24 | 17.25 | 739 | 4929 | 0.1499 | 0.5850 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.24 | 17.25 | 5491 | 4929 | 1.1140 | 1.0266 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.24 | 17.25 | 65 | 4929 | 0.0132 | 0.1766 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 56.24 | 17.25 | 5668 | 4929 | 1.1499 | 1.0345 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 17.25 | 743 | 4942 | 0.1503 | 0.5857 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 17.25 | 5832 | 4942 | 1.1800 | 1.0410 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 17.25 | 37 | 4942 | 0.0075 | 0.0980 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 58.21 | 17.25 | 6068 | 4942 | 1.2277 | 1.0509 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.18 | 17.25 | 543 | 5031 | 0.1079 | 0.5239 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.18 | 17.25 | 6164 | 5031 | 1.2251 | 1.0502 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.18 | 17.25 | 32 | 5031 | 0.0064 | 0.0784 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 60.18 | 17.25 | 6443 | 5031 | 1.2805 | 1.0613 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.15 | 17.25 | 424 | 5061 | 0.0838 | 0.4779 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.15 | 17.25 | 6545 | 5061 | 1.2932 | 1.0637 | MN20160310_N02 | E06 |